Evaluating the Impact of GLP-1 Receptor Agonists With Total Neoadjuvant Therapy in Rectal Cancer

Clinical trial NCT07314528 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07314528
Sponsor: St. James's Hospital, Ireland
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Rectal Cancer Patients Obesity &Amp; Overweight Locally Advanced Rectal Cancer (LARC)Total Neoadjuvant Therapy GLP-1

Start date: 2026-04-01
Primary completion: 2028-09-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.